Ginkgo Bioworks
operating company Β· company profileBoston Β· 1 people tracked
Investment thesis
Ginkgo Bioworks believes that biology represents one of the most important domains for innovation, underlying food production, medicine, and environmental systems. The company emphasizes that while modern education has shifted focus away from the biological world toward human-built technology, there is a critical need to redirect attention and resources toward biological engineering. By developing autonomous laboratory technology, Ginkgo seeks to democratize and accelerate bioengineering capabilities across multiple industries including pharmaceuticals, agriculture, and industrial biotechnology.
Source: firm website, verified Aug 6, 2026.
Team Β· 1 people
from public directories
Founder mafia
The Ginkgo Bioworks mafia β10 people who came through Ginkgo Bioworks went on to found or lead other companies.
Frequently asked questions
- What sectors does Ginkgo Bioworks focus on?
- Ginkgo Bioworks focuses on Biotech, Deep Tech.
- Where is Ginkgo Bioworks located?
- Ginkgo Bioworks is headquartered in Boston, US.
Similar investors
8VC is a venture capital firm investing across logistics, life sciences, healthcare, IT infrastructure, and government/defense, guided by its Smart Enterprise thesis focused on data integration and platform network effects.
ACT Venture Capital is an independent Irish venture capital firm that invests β¬1 million to β¬15 million in growth-stage private companies, with capacity for larger commitments through syndicated rounds.
Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.
Andreessen Horowitz (a16z) is a venture capital firm founded in 2009 by Marc Andreessen and Ben Horowitz, known for pioneering the platform model with a large team of operators supporting founders across stages.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.